lung cancer
Conditions
Interventions
experimental group:para-vertebral block(ropivacaine)
control group:para-vertebral block (saline)
Sponsors
Zhejiang Cancer Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) for patients undergoing thoracoscopic lobectomy/segmental resection; (2) Older than 18 years old and younger than 70 years old; (3) ASA grade I -III; (4) Can cooperate with VAS pain scoring.
Exclusion criteria
Exclusion criteria: (1) Serious cardiopulmonary diseases, including but not limited to severe aortic stenosis, severe mitral stenosis, hemodynamic disorders caused by serious arrhythmias, acute cerebral infarction or myocardial infarction within the last 6 months, cardiac surgery within the last 6 months, etc. Upper respiratory tract infection or lung infection; (2) There are contraindications for paraspinal nerve block, such as puncture site infection, pyoses, kyphosis, previous pulmonary operation history and coagulation dysfunction; (3) Serious organ function diseases such as kidney disease and liver disease, etc. (4) Transfer to open surgery; (5) Opioids taken orally for more than 3 weeks before surgery; (6) The patient refused to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| EC50 of propofol; | — |
Secondary
| Measure | Time frame |
|---|---|
| NRS score; | — |
Countries
China
Contacts
Public ContactWen Zhang
Zhejiang Cancer Hospital
Outcome results
None listed